Primary vs. secondary antibody kinetics
First exposure
- IgM rises first and dominates — it's the default output before class switching occurs.
- IgG rises later, after a lag, and eventually overtakes IgM in titer.
- IgM levels then fall off relatively quickly once IgG production ramps up.
Repeat exposure
- IgG response is faster, higher in magnitude, and more sustained (memory B cells + plasma cells already primed).
- IgM response on re-exposure is blunted — a small IgM bump can still occur, but it no longer dominates.
Why this matters clinically
- Detecting pathogen-specific IgM → implies a recent/first-time (acute) infection, since IgM is always made by cells meeting that antigen for the first time.
- Example: anti-core antibody (IgM) to hepatitis B core antigen signals acute infection — useful during the window period when other markers may be negative.
- Special case — congenital/neonatal infection:
- IgM cannot cross the placenta.
- So pathogen-specific IgM detected in a neonate/fetus must have been made by the baby's own immune system.
- This distinguishes true fetal/neonatal infection (e.g., congenital rubella) from passively acquired maternal IgG antibody.
Idiotype, isotype, allotype — and proteolytic fragments
| Term | Region | What varies |
|---|---|---|
| Idiotype | Variable domains (VH+VL) | Unique per B-cell clone — hundreds of millions possible per person; defines antigen specificity |
| Isotype | Heavy-chain constant region | Same across a class (IgM/IgG/IgA/IgD/IgE) — defines effector function |
| Allotype | Constant region | Minor allelic variation between individuals of the same isotype |
Exam trap: allotypic mismatches are why pooled donor immunoglobulin (IVIG) can occasionally provoke immune-complex (type III hypersensitivity) reactions in a recipient — the recipient's immune system sees the donor constant-region variants as foreign.
Cutting the antibody apart: papain vs. pepsin
Papaincleaves above the inter-chain disulfides→
2× Fab (antigen-binding) + 1× Fc (crystallizable)
Pepsincleaves below the inter-chain disulfides→
1× F(ab′)₂ (both arms still linked) + digested Fc fragments
- Fab/F(ab′)₂ retain antigen-binding capacity; only F(ab′)₂ retains the ability to cross-link two separate antigen molecules (bivalent), since it keeps both arms joined.
- Fc mediates effector binding (complement, Fc receptors) — it carries no antigen specificity.
Antigen–antibody lattice formation
- Visible precipitation/agglutination requires cross-linking — one antibody bridging multiple antigen molecules, and vice versa, into a lattice.
- Maximal lattice formation happens at the zone of equivalence, where antigen and antibody concentrations are proportionate.
| Zone | What's in excess | Precipitate/agglutination |
|---|---|---|
| Antigen excess | Free antigen | Small, soluble complexes — little visible reaction |
| Equivalence | Neither — balanced | Maximal lattice, maximal visible precipitate |
| Antibody excess | Free antibody | Small complexes again — reaction declines |
Clinical illustration: hepatitis B surface antigen/antibody
Early infection: HBsAg detectable (antigen excess)→
Window period: HBsAg and HBsAb both undetectable (equivalence)→
Resolution: HBsAb rises and is detectable (antibody excess)
High-yield: the "window period" in hepatitis B is the one clinically named example of the equivalence zone, but the same three-zone curve applies to any antigen–antibody titration.
Polyclonal vs. monoclonal, direct vs. indirect testing
Polyclonal antiserum
- Made naturally during infection, or by immunizing an animal (mouse, rabbit, goat).
- Mixture of antibodies from many B-cell clones, targeting many epitopes on the same antigen.
Monoclonal antibody
- Single B-cell clone → single epitope specificity.
- Manufactured in the lab; used diagnostically and therapeutically (oncology, autoimmune disease).
Direct testing
- Known antibody is used to detect an unknown antigen.
- Fast, qualitative — good for screening.
Indirect testing
- Patient's own antibodies (against self or foreign antigen) are the analyte being detected.
- Can be qualitative (screening) or quantitative — a quantitative version is called a titer: serial dilution of patient serum to find the highest dilution still giving a positive reaction.
- Generally more specific than direct methods, with fewer false positives.
- Coombs, fluorescent antibody, and ELISA formats can all be run as either direct or indirect assays.
Agglutination and the Coombs test
- Agglutination = precipitation reaction using a particulate antigen (RBCs, latex beads) instead of soluble antigen.
- Latex-bead agglutination: antibody-coated beads clump when they meet matching microbial antigen — used for rapid CSF antigen screens (e.g., encapsulated organisms causing meningitis).
- RBC-based agglutination underlies ABO typing, the heterophile ("monospot") test for EBV, and the Coombs test.
| Coombs variant | What it detects | Typical use |
|---|---|---|
| Direct Coombs | Antibody already bound to the patient's own RBCs in vivo | Autoimmune hemolytic anemia; hemolytic disease of the newborn |
| Indirect Coombs | Free antibody circulating in serum, not yet bound to any RBC | Screening Rh-negative mothers for anti-Rh IgG; pretransfusion crossmatching |
Antibody-coated RBCs+ anti-human-immunoglobulin reagent→
RBC agglutination = positive result
Exam trap: it's the anti-human-globulin ("Coombs reagent") that produces visible clumping by bridging RBCs already coated with antibody — the reagent itself is not specific for Rh.
ABO blood group testing
- ABO antigens are glycoproteins on RBCs and endothelial cells — mismatch causes hyperacute graft/transfusion rejection, so ABO typing precedes essentially all transplantation and transfusion.
- Naturally occurring anti-A/anti-B antibodies ("isohemagglutinins") are IgM, generated against similar carbohydrate structures on normal gut flora.
- Self-tolerance prevents a person from making antibody against their own ABO antigen(s).
| Blood type | RBC antigen | Serum antibody |
|---|---|---|
| A | A | Anti-B |
| B | B | Anti-A |
| AB | A and B | None |
| O | Neither | Anti-A and Anti-B |
High-yield: type O is the "universal donor" for RBCs (no A/B antigen to attack) and type AB the "universal recipient" (no anti-A/anti-B to react with donor cells) — for RBC antigen alone, ignoring Rh.
Labeled antibody systems
Fluorescent antibody tests
DFA (direct):fluorescent-tagged antibody applied directly to a tissue sample→binding = antigen present
IFA (indirect):patient serum incubated with known antigen-bearing tissue→fluorescent anti-human-immunoglobulin added→signal = patient had specific antibody
- DFA-type assays are used for rapid antigen detection (e.g., certain respiratory viruses, herpes simplex, rabies in tissue).
- IFA-type assays detect patient antibody, including autoantibodies in autoimmune disease workups.
Enzyme-linked immunosorbent assay (ELISA)
- Extremely sensitive — can detect antigen/antibody in the nanogram range.
- Core principle: enzyme-labeled antibody binds its target, then a chromogenic substrate is added → enzyme converts it to a colored product → color intensity signals a positive/quantifiable result.
- Classic example — HIV screening: viral capsid antigen coated on a plate → patient serum added → enzyme-labeled anti-human-immunoglobulin added → substrate added → color change = patient antibody present.
- Can be configured as either a direct antigen-detection assay or an indirect antibody-detection assay.
Flow cytometry / fluorescence-activated cell sorting
- Purpose: rapidly quantify and separate cell populations within a mixed sample based on surface markers.
- Cells are labeled with fluorescently tagged antibodies against specific surface CD markers (e.g., CD3, CD4, CD8, CD20).
Labeled cell suspension→
single-file stream past a laser→
fluorescence + light-scatter detected per cell→
plotted on a 2-marker scatter graph→
populations can be physically sorted via deflection plates
- Each dot on the resulting plot represents one cell; dense clusters indicate populations sharing the same marker combination (e.g., CD3+/CD4+ double-positive T cells).
- Used to quantify lymphocyte subsets clinically — classic example: CD4+ T-cell counts in HIV monitoring.